INSIGHTS ON CLINICAL TRIAL PARTNERING

• Accelerating Clinical Supply Through Integrated Drug Development

  See how parallel processing integrates clinical supply into drug development, enabling simultaneous workstreams that address packaging, labeling, and sourcing challenges before manufacturing completes.

• The Rise Of Targeted Modalities In Pharmaceutical Development

  Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.

• Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule

  Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.

• Securing Sponsor Reimbursement For CRIO Fees

  Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.

• Transparent Pricing In Bioanalysis: A Feature, Not A Bonus

  3/9/2026

  Unclear CRO pricing leaves small biotechs vulnerable to budget swings. Transparent, itemized costs cut financial risk, sharpen planning, and build trust by setting expectations from the start.

• Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments

  1/15/2025

  Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

• 5 Outdated Practices Holding Back Modern Bioanalysis

  10/20/2025

  Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.

• Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial

  3/9/2026

  Evaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.

• Why Are Clinical Research Meetings Harder To Plan Right Now?

  6/19/2026

  Are your clinical meetings setting your study up for success, or creating avoidable challenges? Watch the presentation to learn how to build alignment from the start.